Effect of Resveratrol on Leptin and Sirtuin 2 Expression in the Kidneys in Streptozotocin-induced Diabetic Rats

被引:0
作者
Yaylah, Ash [1 ]
Ergin, Kemal [2 ]
Cecen, Serpil [3 ]
机构
[1] Kahramanmaras Sutcu Imam Univ, Fac Med, Dept Histol & Embryol, TR-46050 Kahramanmaras, Turkey
[2] Adnan Menderes Univ, Fac Med, Dept Histol & Embryol, Aydin, Turkey
[3] Marmara Univ, Fac Med, Dept Physiol, Istanbul, Turkey
来源
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY | 2015年 / 37卷 / 04期
关键词
diabetes mellitus; diabetic kidney disease; diabetic nephropathy; leptin; resveratrol; sirtuin; 2; OXIDATIVE STRESS; NEPHROPATHY; PROGRESSION; PROTECTION; SECRETION; CYTOKINES; INSULIN; DISEASE; SIR2;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
OBJECTIVE: To investigate the effect of resveratrol (RSV) on the histo pathology and leptin and sirtuin 2 expression levels of the kidneys in streptozotocin (STZ)-induced diabetic rats. STUDY DESIGN: The study was carried out with 33 young, healthy, female Wistar Albino rats. STZ was given (50 mg/kg, intraperitoneal, single dose) to the rats to induce and constitute a diabetes model. After 1 month of STZ, resveratrol (10 mg/kg) was given for 15 days. Then the kidneys were evaluated histo pathologically and the leptin and sirtuin 2 expressions were analyzed immunohistochemically. RESULTS: High glucose and fewer weight levels were seen in the STZ-induced diabetes mellitus group. The glucose levels in the RSV-administered diabetic group showed a tendency to decrease but not significantly. Decreased signs of histopathologic kidney damage was seen in the RSV-administered diabetic group, and an increased expression of leptin was seen in the diabetic kidney tissues. There were no significant differences of sirtuin 2 expression levels among the groups. CONCLUSION: It was observed that resveratrol caused changes in the diabetic kidney histology and leptin expression level. Resveratrol may be effective, with its antioxidant and antidiabetic effects, in the prevention of kidney damage caused by long-term hyperglycemia.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 37 条
[1]   Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats [J].
Ates, Ozkan ;
Cayli, Suleyman R. ;
Yucel, Neslihan ;
Altinoz, Eyup ;
Kocak, Ayhan ;
Durak, M. Akif ;
Turkoz, Yusuf ;
Yologlu, Saim .
JOURNAL OF CLINICAL NEUROSCIENCE, 2007, 14 (03) :256-260
[2]  
Buyukdevrim SA, 2005, DIYABETIK NEFROPATI, V1, p[84, 114, 481]
[3]   EPIDEMIOLOGY OF END-STAGE RENAL-DISEASE IN PATIENTS WITH DIABETES-MELLITUS - FROM THE DARK AGES TO THE MIDDLE-AGES [J].
CATALANO, C ;
MARSHALL, SM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (03) :181-190
[4]   Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase [J].
Chang, Chih-Chun ;
Chang, Chieh-Yu ;
Wu, Yang-Tzu ;
Huang, Jiung-Pang ;
Yen, Tzung-Hai ;
Hung, Li-Man .
JOURNAL OF BIOMEDICAL SCIENCE, 2011, 18
[5]   Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats [J].
Chen, Kuan-Hsing ;
Hung, Cheng-Chieh ;
Hsu, Hsiang-Hao ;
Jing, Yu-Hong ;
Yang, Chih-Wei ;
Chen, Jan-Kan .
CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 190 (01) :45-53
[6]   Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control [J].
Dao, Thi-Mai Anh ;
Waget, Aurelie ;
Klopp, Pascale ;
Serino, Matteo ;
Vachoux, Christelle ;
Pechere, Laurent ;
Drucker, Daniel J. ;
Champion, Serge ;
Barthelemy, Sylvain ;
Barra, Yves ;
Burcelin, Remy ;
Seree, Eric .
PLOS ONE, 2011, 6 (06)
[7]   Resveratrol Attenuates Renal Hypertrophy in Early-Stage Diabetes by Activating AMPK [J].
Ding, Da-Fa ;
You, Na ;
Wu, Xiao-Mei ;
Xu, Jia-Rong ;
Hu, Ai-Ping ;
Ye, Xiao-Long ;
Zhu, Qun ;
Jiang, Xiu-Qing ;
Miao, Heng ;
Liu, Chao ;
Lu, Yi-Bing .
AMERICAN JOURNAL OF NEPHROLOGY, 2010, 31 (04) :363-374
[8]   Minireview -: Biological effects of resveratrol [J].
Frémont, L .
LIFE SCIENCES, 2000, 66 (08) :663-673
[9]   Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria [J].
Fruehwald-Schultes, B ;
Kern, W ;
Beyer, J ;
Forst, T ;
Pfützner, A ;
Peters, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (10) :1290-1293
[10]  
Goldman L, 2006, CECIL TXB MED, V22, P1424